7Baggers
 XGN: Virtual Meeting Scheduled for November 24th  GuruFocus Fri, 14 Nov 2025 16:45:30 GMT
 Exagen Inc. to Participate in Fourth Quarter Investor Conferences  GlobeNewswire Tue, 11 Nov 2025 14:00:00 GMT
 Exagen price target raised to $15 from $13 at BTIG  TipRanks Mon, 10 Nov 2025 12:53:51 GMT
 BTIG Maintains Exagen (XGN) Buy Recommendation  Nasdaq Mon, 10 Nov 2025 12:02:00 GMT
 published on: 2025-11-10 00:30:44  newser.com Mon, 10 Nov 2025 06:30:44 GMT
 can exagen inc. stock hit record highs again - 2025 growth vs value & weekly momentum picks  Fundação Cultural do Pará Thu, 06 Nov 2025 12:43:20 GMT
 Exagen Delivers Revenue Growth But Still Sees Losses  Finimize Wed, 05 Nov 2025 21:02:01 GMT
 Exagen (XGN) Sees Target Price Raised by B. Riley Securities | X  GuruFocus Wed, 05 Nov 2025 18:05:25 GMT
 Exagen Inc. (NASDAQ:XGN) Q3 2025 Earnings Call Transcript  Insider Monkey Wed, 05 Nov 2025 13:29:31 GMT
 exagen inc. reports strong q3 2025 performance  TipRanks Wed, 05 Nov 2025 05:46:25 GMT
 exagen’s earnings call: growth amid financial hurdles  TipRanks Wed, 05 Nov 2025 01:10:45 GMT
 transcript : exagen inc., q3 2025 earnings call, nov 04, 2025  MarketScreener Tue, 04 Nov 2025 21:10:45 GMT
 william blair maintains exagen(xgn.us) with buy rating  富途牛牛 Tue, 04 Nov 2025 20:31:00 GMT
 exagen delivers revenue growth but still sees losses  Finimize Tue, 04 Nov 2025 16:39:18 GMT
 xgn forecasts positive adjusted ebitda by q4 2025  GuruFocus Tue, 04 Nov 2025 13:55:31 GMT
 XGN Reports Q3 Revenue Surpassing Expectations  GuruFocus Tue, 04 Nov 2025 13:55:30 GMT
 Exagen Inc (XGN) Q3 2025 Earnings: Revenue Surpasses Estimates a  GuruFocus Tue, 04 Nov 2025 13:41:23 GMT
 Exagen Inc. Reports Strong Q3 2025 Results  GlobeNewswire Tue, 04 Nov 2025 13:00:00 GMT
 Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT

Exagen Inc
(NASDAQ:XGN) 

XGN stock logo

Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enables rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmun...

Founded: 2002
IPO Price: $14 (Sep 19, 2019)
Full Time Employees: 153
CEO: Fortunato Ron Rocca  
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends